Evidence map›Paper›PMID 38391896›Full record

ArticleJournal of functional biomaterials2024

Surface Modification Strategies for Chrysin-Loaded Iron Oxide Nanoparticles to Boost Their Anti-Tumor Efficacy in Human Colon Carcinoma Cells.

Aynura Karimova, Sabina Hajizada, Habiba Shirinova, Sevinj Nuriyeva, Lala Gahramanli, Mohammed M Yusuf, Stefano Bellucci, Christoph Reissfelder, Vugar Yagublu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of functional biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Aynura KarimovaNanoresearch Laboratory, Baku State University, Baku AZ 1148, Azerbaijan.ORCID 0000-0002-5706-2566
Sabina HajizadaDepartment of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.ORCID 0009-0008-6912-5932
Habiba ShirinovaNanoresearch Laboratory, Baku State University, Baku AZ 1148, Azerbaijan.
Sevinj NuriyevaNanoresearch Laboratory, Baku State University, Baku AZ 1148, Azerbaijan.
Lala GahramanliNanoresearch Laboratory, Baku State University, Baku AZ 1148, Azerbaijan.
Mohammed M YusufDepartment of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Stefano BellucciLaboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, 00044 Frascati, Italy.ORCID 0000-0003-0326-6368
Christoph ReissfelderDepartment of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.ORCID 0000-0003-4591-1046
Vugar YagubluDepartment of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Baku State University · AZHeidelberg University · DEIstituto Nazionale di Fisica Nucleare · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancing nanoparticles' anti-cancer capabilities as drug carriers requires the careful adjustment of formulation parameters, including loading efficiency, drug/carrier ratio, and synthesis method. Small adjustments to these parameters can significantly influence the drug-loading efficiency of nanoparticles. Our study explored how chitosan and polyethylene glycol (PEG) coatings affect the structural properties, drug-loading efficiency, and anti-cancer efficacy of Fe

Indexed as

coating agentscolon cancerdrug concentrationloading efficiencymagnetite nanoparticles

Identifiers

PMID38391896
PMCPMC10889794
OpenAlexW4391785678

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.